Fig. 4From: Knockdown of ALPK2 inhibits the development and progression of Ovarian CancerKnockdown of ALPK2 inhibits tumor growth in mice xenograft models. a The volume of tumors in shCtrl group and shALPK2 group was measured post-injection. b The average weight of tumors in shCtrl group and shALPK2 group. c The photos of tumors in shCtrl group and shALPK2 group. d The total bioluminescent intensity of tumors in shCtrl group and shALPK2 group. e The bioluminescence imaging of tumors in shCtrl group and shALPK2 group. f Images of the tumor tissues of the shCtrl group and shALPK2 group with Ki-67 staining. The data were expressed as mean ± SD (n = 3), *P < 0.05, **P < 0.01, ***P < 0.001Back to article page